Stevanato Group S.p.A (STVN) Gains from Investment Securities (2021 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Gains from Investment Securities of $104196.4 for Q1 2026, up 1018.91% quarter-over-quarter from $9312.3 in Q4 2025.
Stevanato Group S.p.A (STVN) Gains from Investment Securities (2021 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Gains from Investment Securities for 6 consecutive years, with $104196.4 the latest figure, recorded in Q1 2026.
- In Q1 2026, Gains from Investment Securities changed N/A year-over-year to $104196.4; the TTM figure through Mar 2026 stood at $145466.1 (changed N/A YoY), while the FY2025 annual figure was -$74498.8, up 13.93% from the prior year.
- Gains from Investment Securities rose to $104196.4 in Q1 2026 per STVN's latest filing, from $9312.3 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $568877.7 in Q3 2024 and bottomed at -$729052.9 in Q2 2024.
- Historically, Gains from Investment Securities has averaged -$48758.4 across 5 years, with a median of -$7141.7 in 2022.
- Annual changes were most pronounced in 2023 — Gains from Investment Securities plunged 6754.82% — and 2024, when it soared 1261.29%.
- Stevanato Group S.p.A's Gains from Investment Securities stood at -$7141.7 in 2022, then slumped by 6754.82% to -$489552.7 in 2023, then soared by 106.77% to $33126.5 in 2024, then plunged by 71.89% to $9312.3 in 2025, then jumped by 1018.91% to $104196.4 in 2026.
- Business Quant data shows STVN's Gains from Investment Securities at $104196.4 in Q1 2026, $9312.3 in Q4 2025, and -$1169.1 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 144,132.87 |
| Jun 30, 2026 | 144,132.87 |
| Mar 31, 2026 | 104,196.36 |
| Mar 31, 2026 | 104,196.36 |
| Dec 31, 2025 | 9,312.35 |
| Dec 31, 2025 | 9,312.35 |
| Sep 30, 2025 | -1,169.06 |
| Sep 30, 2025 | -1,169.06 |
| Dec 31, 2024 | 33,126.46 |
| Dec 31, 2024 | 33,126.46 |
| Sep 30, 2024 | 568,877.70 |
| Sep 30, 2024 | 568,877.70 |
| Jun 30, 2024 | -729,052.89 |
| Jun 30, 2024 | -729,052.89 |
| Mar 31, 2024 | 51,059.00 |
| Mar 31, 2024 | 51,059.00 |
| Dec 31, 2023 | -489,552.66 |
| Dec 31, 2023 | -489,552.66 |
| Sep 30, 2023 | -48,986.57 |
| Sep 30, 2023 | -48,986.57 |